TLSI
TriSalus Life Sciences Inc.
4.30$
-5.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.2% | +12.9% | +14.0% | -0.2% | +12.4% | +11.0% | +22.3% | +3.1% | +14.2% | -32.6% | +28.2% | – | |
| – | -1.2% | +66.8% | -6.1% | +10.1% | +21.1% | +22.9% | +20.5% | +5.8% | -7.6% | -30.2% | +22.6% | – | |
| – | +11.6% | +6.8% | +17.6% | -1.7% | +11.0% | +8.9% | +22.7% | +2.6% | +18.5% | -33.0% | +29.1% | – | |
| – | -19.6% | -23.3% | -20.3% | -9.6% | -29.9% | +11.4% | +19.0% | +31.9% | -50.3% | +25.1% | -2.5% | – | |
| – | -33.4% | -23.1% | -14.5% | +19.5% | +146.8% | -57.4% | +13.8% | +17.7% | -37.4% | +30.7% | -5.4% | – | |
| – | -17.1% | -10.8% | -14.8% | +3.1% | +5.0% | -5.3% | +11.6% | +11.5% | -21.2% | +9.3% | +22.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -25.0% | +0.0% | +29,133.3% | +30.2% | -6.5% | +13.2% | +17.7% | +2.6% | -0.5% | -1.1% | +3.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -695.1% | – | |
| – | – | +200.0% | +133.3% | -142.9% | – | – | -160.0% | – | -380.0% | – | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -696.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -338.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.